While community prostate-specific antigen (PSA) testing can lead to the early detection and diagnosis of prostate cancer this test has a low specificity, and the optimal threshold for biopsy is unclear (Thompson et al, 2003). The gene discussed is KLK3; the disease is prostate carcinoma.